Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,408
Total Claims
$1.2M
Drug Cost
411
Beneficiaries
$2,853
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-15%
Opioid rate vs peers
3.2% vs 3.8% avg
+143%
Cost per patient vs peers
$2,853 vs $1,174 avg
-1%
Brand preference vs peers
8.8% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
621
Opioid Claims
$14K
Opioid Cost
7.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,702 claims · $875K
Generic: 17,653 claims · $296K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 320 | $174K |
| Insulin Glargine,hum.Rec.Anlog | 174 | $75K |
| Dulaglutide | 62 | $60K |
| Semaglutide | 49 | $47K |
| Rivaroxaban | 73 | $41K |
| Mirabegron | 84 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 83 | $32K |
| Sitagliptin Phosphate | 33 | $22K |
| Linagliptin | 37 | $19K |
| Cariprazine Hcl | 13 | $18K |
| Empagliflozin | 26 | $15K |
| Linaclotide | 24 | $13K |
| Erenumab-Aooe | 16 | $12K |
| Potassium Chloride | 716 | $9,729 |
| Sacubitril/Valsartan | 15 | $9,628 |
Prescribing Profile
Patient Profile
80
Avg Age
69%
Female
1.93
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About